[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-337721-105":59,"doc-detail-337721-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","resf1-is-a-compound-g4-quadruplex-associated-tumor-suppressor-for-triple-negative-breast-cancer","Resf1 is a compound G4 quadruplex-associated tumor suppressor for triple negative breast cancer","","Patients with ER-negative breast cancer show the poorest prognosis, frequently developing rapid recurrence or metastatic progression soon after diagnosis. Because metastasis drives mortality in most solid tumors, identifying metastatic biology is critical for intervention. Using a mouse systems genetics strategy, the study expands prior findings to nominate Resf1, a poorly characterized metastasis susceptibility gene, as a tumor suppressor. CRISPR or gene-trap models reduce Resf1, increasing tumor growth, shortening survival, and elevating lung metastases, aligning with patient data.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/resf1-is-a-compound-g4-quadruplex-associated-tumor-suppressor-for-triple-negative-breast-cancer/337721/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/resf1-is-a-compound-g4-quadruplex-associated-tumor-suppressor-for-triple-negative-breast-cancer/337721.png","ImageObject",300,407,{"name":92,"@type":93},"Aurora","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-05","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"Why is metastasis especially important in ER-negative breast cancer?","Question",{"text":113,"@type":114},"ER-negative patients have the worst outcomes, with rapid recurrence or progression to metastatic disease. Since metastatic disease drives most mortality, preventing or treating metastasis is critical.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"What evidence supports Resf1 as a metastasis-related tumor suppressor?",{"text":118,"@type":114},"Mouse CRISPR or gene-trap models with reduced Resf1 show increased tumor growth, reduced overall survival, and more lung metastases. Matched tissue analysis shows loss of the wildtype copy in tumor tissue, consistent with tumor suppressor function.",{"name":120,"@type":111,"acceptedAnswer":121},"How might Resf1 influence metastasis mechanistically?",{"text":122,"@type":114},"Mechanistic analyses suggest Resf1 may regulate transcription by associating with compound G4 quadruplexes in expressed sequences, particularly those linked to ribosomal biogenesis. Loss of Resf1 is proposed to affect both transcriptional and translational control.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},337721,1790163659,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},4810365810221,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","PLOS GENETICS  \nOPEN ACCESS  \nCitation: Majocha MR, Jackson DE, Ha N-H, Amin R, Pangr´acov´a M, Ross CR, et al. (2024) Resf1 is a compound G4 quadruplex-associated tumor suppressor for triple negative breast cancer. PLoS Genet 20(5): e1011236 . [https://doi.org/10.1371/](https://doi.org/10.1371/)[ ](https://doi.org/10.1371/)[journal.pgen.1011236](journal.pgen.1011236)  \nEditor: Danny R. Welch, The Kansas University Medical Center, UNITED STATES  \nReceived: January 18, 2024  \nAccepted: March 27, 2024  \nPublished: May 9, 2024  \nCopyright: This is an open access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication.  \nData Availability Statement: The Next Generation Sequencing data described in this manuscript has been deposited in the Gene Expression Omnibus, accession number GSE255393 .  \nFunding: This work was supported by the National Institutes of Health (ZIA BC 011255 to KWH) . The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.  \nCompeting interests: The authors have declared that no competing interests exist.  \nRESEARCH ARTICLE  \nResf1 is a compound G4 quadruplexassociated tumor suppressor for triple negative breast cancer  \nMegan R. Majocha1,2☯, Devin E. Jackson1,2☯, Ngoc-Han Ha1, Ruhul Amin1, Marie Pangr´acov´a1, Christina R. Ross1, Howard H. Yang1, Maxwell P. Lee1, Kent W. Hunter1 *  \n1 Laboratory of Cancer Biology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America, 2 Lombardi Comprehensive Cancer Center, Georgetown University, Washington DC, United States of America  \n☯ These authors contributed equally to this work.  \n* [hunterk@mail.nih.gov](hunterk@mail.nih.gov)  \nAbstract  \nPatients with ER-negative breast cancer have the worst prognosis of all breast cancer subtypes, often experiencing rapid recurrence or progression to metastatic disease shortly after diagnosis. Given that metastasis is the primary cause of mortality in most solid tumors, understanding metastatic biology is crucial for effective intervention. Using a mouse systems genetics approach, we previously identified 12 genes associated with metastatic susceptibility. Here, we extend those studies to identify Resf1 , a poorly characterized gene, asa novel metastasis susceptibility gene in ER-breast cancer. Resf1 is a large, unstructured protein with an evolutionarily conserved intron-exon structure, but with poor amino acid conservation. CRISPR or gene trap mouse models crossed to the Polyoma Middle-T antigen genetically engineered mouse model (MMTV-PyMT) demonstrated that reduction of Resf1 resulted in a significant increase in tumor growth, a shortened overall survival time, and increased incidence and number of lung metastases, consistent with patient data. Furthermore, an analysis of matched tail and primary tissues revealed loss of the wildtype copy in tumor tissue, consistent with Resf1 being a tumor suppressor. Mechanistic analysis revealed a potential role of Resf1 in transcriptional control through association with compound G4 quadruplexes in expressed sequences, particularly those associated with ribosomal biogenesis. These results suggest that loss of Resf1 enhances tumor progression in ER-breast cancer through multiple alterations in both transcriptional and translational control.  \nAuthor summary  \nMetastasis is the major cause of breast cancer deaths. However, unlike the primary tumor, acquired mutations do not appear to play a significant role in the development ofmetastatic disease. A person’s individual ancestry, however, does significantly influence  \nmetastatic efficiency. Our laboratory therefore seeks to identify and characterize the differences in inherited genes that increase or decrease metastatic burden. O","cbCaignfqJtqQGwy","https://ap.wps.com/l/cbCaignfqJtqQGwy","pdf",3485337,31,"English","# Abstract\n## Introduction\n## Author Summary","[{\"question\":\"Why is metastasis especially important in ER-negative breast cancer?\",\"answer\":\"ER-negative patients have the worst outcomes, with rapid recurrence or progression to metastatic disease. Since metastatic disease drives most mortality, preventing or treating metastasis is critical.\"},{\"question\":\"What evidence supports Resf1 as a metastasis-related tumor suppressor?\",\"answer\":\"Mouse CRISPR or gene-trap models with reduced Resf1 show increased tumor growth, reduced overall survival, and more lung metastases. Matched tissue analysis shows loss of the wildtype copy in tumor tissue, consistent with tumor suppressor function.\"},{\"question\":\"How might Resf1 influence metastasis mechanistically?\",\"answer\":\"Mechanistic analyses suggest Resf1 may regulate transcription by associating with compound G4 quadruplexes in expressed sequences, particularly those linked to ribosomal biogenesis. Loss of Resf1 is proposed to affect both transcriptional and translational control.\"}]","Resf1 is a compound G4 quadruplex-associated tumor suppressor for triple negative breast cancer | PDF",1790020346,78,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/64ebc24929fb577ff1b07495d458c749.webp",983,1272,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/17b7e9cb3a0cdd3a4f7e25f1fb9b930d.webp",982,1270,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3615b57f599162702bd44bb7882d08a5.webp",981,1269,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/af7569aaceba023dc7901b643a145dd7.webp",980,1268]